OURVIA
Understanding Fertility Together.
Assessing both partners in parallel can reveal the combined picture. Ovulation, tubes, the uterus and sperm need different questions and tests; responsibility should not fall on one partner alone.
Educational preview. Clinical review pending.
Understand The Combined Picture.
Ovulation, tubes, uterus and sperm: each assessment answers a different question. Bring the results together before choosing between trying without treatment, IUI, IVF or another approach.
Carrier screening: this examines selected inherited-condition risks for a future child. It is not a general pass/fail fertility or compatibility test. Genetic counselling can explain findings.
KIR and HLA-C: specialists study how these immune-related markers might interact during placental development. Testing is emerging and does not establish a validated compatibility verdict or result.
Infection and microbiome: testing for a suspected infection is different from a broad microbiome add-on. Sampling, test definitions and evidence for treatment benefit vary. A detected organism or pattern is not automatically the cause of a transfer failure.
Reviewing decisions together: keep the full reports, treatment chronology and laboratory explanations. A second opinion can review what is established, what remains uncertain and why the same plan is being repeated or changed.
Project Status
HERVIA clinical services, bookings, laboratory arrangements and clinical result-review pathways are in development. Availability and prices are not confirmed. This website provides educational information and enquiries, not a clinical booking service.
Need More Information?
Contact the HERVIA team for general questions about these resources or service development.
OURVIA is an educational concept in development. It does not currently offer clinical review, medical advice, diagnosis, or active treatment.